Stage-associated dynamic activity profile of transcription factors in nasopharyngeal carcinoma progression based on protein/DNA array analysis

OMICS A Journal of Integrative Biology

Volumn 15, Issue 1-2, 2011, Pages 49-60

  Su, Bo ^a,b   Tang, Hai Lin ^a,b   Deng, Min ^a,b   Liao, Qian Jin ^a,b   Zeng, Xi ^a,b   Zhang, Wen Ling ^a   Xiang, Bo ^a   Wang, Li ^a   Li, Xiao Ling ^a   Li, Xia Yu ^a   Wu, Ming Hua ^a   Li, Gui Yuan ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b UNIVERSITY OF SOUTH CHINA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 1; ACTIVATING TRANSCRIPTION FACTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR; GELATINASE A; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 2;

ADULT; ARTICLE; CANCER GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BASE SEQUENCE; BLOTTING, WESTERN; DISEASE PROGRESSION; DNA PROBES; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS;

EID: 79551548442     PISSN: 15362310     EISSN: None     Source Type: Journal    
DOI: 10.1089/omi.2010.0055     Document Type: Article

References (46)

1. Bhoumik, A., and Ronai, Z. (2008). ATF2: a transcription factor that elicits oncogenic or tumor suppressor activities. Cell Cycle 7, 2341-2345.
2. Buettner, R., Mora, L.B., and Jove, R. (2002). Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention. Clin Cancer Res 8, 945-954.
3. Carson, A., and Khan, S.A. (2006). Characterization of transcription factor binding to human papillomavirus type 16 DNA during cellular differentiation. J Virol 80, 4356-4362.
4. Chan, A.T.C., Teo, P.M.L., and Johnson, P.J. (2002). Nasopharyngeal carcinoma. Ann Oncol 13, 1007-1015.
5. Chen, H.L., Lee, J.M., Zong, Y.S., Borowitz, M., Ng, M.H., Ambinder, R.F., et al2001). Linkage between STAT regulation and Epstein-Barr virus gene expression in tumors. J Virol 75, 2929-2937.
6. Dam, H.V., and Castellazzi, M. (2001). Distinct roles of Jun:Fos and Jun:ATF dimers in oncogenesis. Oncogene 20, 2453-2464.
7. Deng, W.G., Jayachandran, G., Wu, G., Xu, K., Roth, J.A., and Ji, L. (2007). Tumor-specific activation of human telomerase reverses transcriptase promoter activity by activating enhancer-binding protein-2beta in human lung cancer cells. J Biol Chem 282, 26460-26470.
8. Durbin, B., and Rocke, D.M. (2003). Estimation of transformation parameters for microarray data. Bioinformatics 19, 1360-1367.
9. Fujii, M., Yamashita, T., Ishiguro, R., Tashiro, M., and Kameyama, K. (2002). Significance of epidermal growth factor receptor and tumor associated tissue eosinophilia in the prognosis of patients with nasopharyngeal carcinoma. Auris Nasus Larynx 29, 175-181.
10. Gimeno, A.B., and Nieto, M.A. (2005). The Snail genes as inducers of cell movement and survival: implications in development and cancer. Development 132, 3151-3161.
11. Heimberger, A.B., McGary, E.C., Suki, D., Ruiz, M., Wang, H., Fuller, G.N., et al2005). Loss of the AP-2a transcription factor is associated with the grade of human gliomas. Clin Cancer Res 11, 267-272.
12. Huang, J., Liao, G.L., Chen, H.L., Wu, F.Y., Fletcher, L.H., Hayward, G.S., et al2006). Contribution of C/EBP proteins to Epstein-Barr virus lytic gene expression and replication in epithelial Cells. J Virol 80, 1098-1109.
13. Huang, Y., Minigh, J., Miles, S., and Niles, R.M. (2008). Retinoic acid decreases ATF-2 phosphorylation and sensitizes melanoma cells to taxol-mediated growth inhibition. J Mol Signal 3,1-11.
14. Hui, A.B., Lo, K.W., Teo, P.M., To, K.F., and Huang, D.P. (2002). Genome wide detection of oncogene amplifications in nasopharyngeal carcinoma by array based comparative genomic hybridization. Int J Oncol 20, 467-473.
15. Hui, E.P., Chan, A.T.C., Pezzella, F., Turley, H., To, K.F., Poon, T.C.W., et al2002). Coexpression of hypoxia-inducible factors 1 and 2, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to Survival. Clin Cancer Res 8, 2595-2604.
16. Jager, R.,Werling, U., Rimpf, S., Jacob, A., and Schorle, H. (2003). Transcription factor AP-2g stimulates proliferation and apoptosis and impairs differentiation in a transgenic model. Mol Cancer Res 1, 921-929.
17. Jean, D., Tellez, C., Huang, S., Davis, D.W., Bruns, C.J., McConkey, D.J., et al2000). Inhibition of tumor growth and metastasis of human melanoma by intracellular anti-ATF-1 single chain Fv fragment. Oncogene 19, 2721-2730.
18. Khodarev, N.N., Beckett, M., Labay, E., Darga, T., Roizman, B., and Weichselbaum, R.R. (2004). STAT1 is overexpressed in tumors selected for radioresistance and confers protection from radiation in transduced sensitive cells. Proc Natl Acad Sci USA 101, 1714-1719.
19. Kim, E.S., Sohn, Y.W., and Moon, A. (2007). TGF-beta-induced transcriptional activation of MMP-2 is mediated by activating transcription factor (ATF)2 in human breast epithelial cells. Cancer Lett 252, 147-156.
20. Kwong, J., Lo, K.W., To, K.F., Teo, P.M.L., Johnson, P.J., and Huang, D.P. (2002). Promoter Hypermethylation of multiple genes in nasopharyngeal carcinoma. Clin Cancer Res 8, 131-137.
21. Lai, J.P., Tong, C.L., Hong, C., Xiao, J.Y., Tao, Z.D., Zhang, Z., et al2002). Association between high initial tissue levels of cyclin d1 and recurrence of nasopharyngeal carcinoma. Laryngoscope 112, 402-408.
22. Li, G.Y., Liu, H.Y., Zhou, M., Zhou, H.D., and Li, X.L. (2006). The molecular mechanism involved in the development of nasopharyngeal carcinoma. Prog Biochem Biophys 30, 922-931.
23. Lu, Q.L., Elia, G., Lucas, S., and Thomas, J.A. (1993). Bcl-2 proto-oncogene expression in Epstein Barr virus associated nasopharyngeal carcinoma. Int J Cancer 53, 29-35.
24. Ma, J., Zhou, J., Fan, S.Q., Wang, L.L., Li, X.L., Yan, Q., et al2005). Role of a novel EGF-like domain-containing gene NGX6 in cell adhesion modulation in nasopharyngeal carcinoma cells. Carcinogenesis 26, 281-291.
25. Maijgren, S., Sur, I., Nilsson, M., and Toftgard, R. (2004). Involvement of RFX proteins in transcriptional activation from a Ras-responsive enhancer element. Arch Dermatol Res 295,482-489.
26. Melnikova,V.O., Zeidan, A.A.M., Lev, D.C., and Eli, M.B. (2006). Platelet-activating factor mediates MMP-2 Expression and activation via phosphorylation of cAMP-response elementbinding protein and contributes to melanoma metastasis. J Biol Chem 281, 2911-2922.
27. Oneil, J.D., Owen, T.J., Wood, V.H.J., Date, K.L., Valentine, R., Chukwuma, M.B., et al2008). Epstein-Barr virus-encoded EBNA1 modulates the AP-1 transcription factor pathway in nasopharyngeal carcinoma cells and enhances angiogenesis in vitro. J Gen Virol 89, 2833-2842.
28. Orso, F., Penna, E., Cimino, D., Astanina, E., Maione, F., Valdembri, D., et al2008). AP-2a and AP-2g regulate tumor progression via specific genetic programs. FASEB J 22, 2702-2714.
29. Oyama, N., Takahashi, H., Tojo, M., Iwatsuki, K., Iizuka, H., Nakamura, K., et al2002). Different properties of three isoforms (alpha, beta, and gamma) of transcription factor AP-2 in the expression of human keratinocyte genes. Arch Dermatol Res 294, 273-280.
30. Paonessa, F., Foti, D., Costa, V., Chiefari, E., Brunetti, G., Leone, F., et al2006). Activator protein-2 overexpression accounts for increased insulin receptor expression in human breast cancer. Cancer Res 66, 5085-5093.
31. Popa, C., Dahler, A.L., Auret, S.M.M., Wong, C.F., Smith, L., Barnes, L.M., et al2004). AP-2 transcription factor family member expression, activity, and regulation in human epidermal keratinocytes in vitro. Differentiation 72, 185-197.
32. Porter,M.J., Field, J.K., Leueg, S.F., Lo, D., Lee, J.C., Spandidos, D.A., et al1994) .The detection of the c-myc and ras oncogenes in nasopharyngeal carcinoma by immunohistochemistry. Acta Otolaryngol 114, 105-109.
33. Qian, C.N., Guo, X., Cao, B., Kort, E.J., Lee, C.C., Chen, J.D., et al2002). Met protein expression level correlates with survival in patients with late-stage nasopharyngeal carcinoma. Cancer Res 62, 589-596.
34. Rayet, B., and Gelinas, C. (1999). Aberrant rel/nfkb genes and activity in human cancer. Oncogene 18, 6938-6947.
35. Saban, R., Simpson, C., Davis, C.A., Dozmorov, I., Maier, J., Fowler, B., et al2007). Transcription factor network downstream of protease activated receptors (PARs) modulating mouse bladder inflammation. BMC Immunol 8, 1-21.
36. Schwartz, B., Melnikova, V.O., Tellez, C., Zeidan, A.M., Blehm, K., Zhao, Y.J., et al2007). Loss of AP-2 alpha results in deregulation of E-cadherin and MMP-9 and an increase in tumorigenicity of colon cancer cells in vivo. Oncogene 26, 4049-4058.
37. Sengupta, P.K., Fargo, J., and Smith, B.D. (2002). The RFX family interacts at the collagen (COL1A2) start site and represses transcription. J Biol Chem 277, 24926-24937.
38. Sriuranpoeng, V., Mutirangura, A., Gillespie, J.W., Patel, V., Amornphimolyham, P., Molinolo, A.A., et al2004). Global gene expression profile of nasopharyngeal carcinoma by laser capture microdissection and complementary DNA microarrays. Clin Cancer Res 10, 4944-4958.
39. Su, B., Xiang, B., Wang, L., Cao, L., Xiao, L., Li, X.Y., et al2010). Profiling and comparing TFs activated in non-metastatic and metastatic nasopharyngeal carcinoma cells. J Cell Biochem 109, 173-183.
40. Sun, L., Diamond, M.E., Ottaviano, A.J., Joseph, M.J., Ananthanarayan, V., and Munshi, H.G. (2008). Transforming growth factor-b1 promotes matrix metalloproteinase-9-mediated oral cancer invasion through Snail Expression. Mol Cancer Res 6, 10-20.
41. Tamoto, E., Tada, M., Murakawa, K., Takada, M., Shindo, G., Teramoto, K.I., et al2004). Gene-expression profile changes correlated with tumor progression and lymph node metastasis in esophageal cancer. Clin Cancer Res 10, 3629-3638.
42. Thornburg, N.J., Pathmanathan, R., and Traub, N.R. (2003). Activation of nuclear factor-kB p50 homodimer/Bcl-3 complexes in nasopharyngeal carcinoma. Cancer Res 63, 8293-8301.
43. Tsai, C.L., Li, H.P., Lu, Y.J., Hsueh, C., Liang, Y., Chen, C.L., et al2006). Activation of DNA methyltransferase 1 by EBV LMP1 involves c-Jun NH2-Terminal kinase signaling. Cancer Res 66, 11668-11676.
44. Wang, L.L., Ma, J., Li, J., Li, X., Zhang, Q.H., Peng, S., et al2005). NGX6 gene inhibits cell proliferation and plays a negative role in EGFR pathway in nasopharyngeal carcinoma cells. J Cell Biochem 95, 64-73.
45. Xu, Y., Sengupta, P.K., Seto, E., and Smith, B.D. (2006). Regulatory factor for X-box family proteins differentially interact with histone deacetylases to repress collagen a2(I) gene (COL1A2) expression. J Biol Chem 281, 9260-9270.
46. Zhou, J., Ma,J., Zhang, B.C., Li, X.L., Shen, S.R., Zhu, S.G., et al2004). BRD7, a novel bromodomain gene, inhibits G1-S progression by transcriptionally regulating some important molecules involved in Ras/MEK/ERK and Rb/E2F pathways. J Cell Physiol 200, 89-98.